Related Experiment Video
Updated: May 30, 2026

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
Published on: July 14, 2023
Cell sources for bone regeneration: the good, the bad, and the ugly (but promising)
1Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA. probey@dir.nidcr.nih.gov
Abstract:
Based on the extensive investigation of various ways to regenerate bone, bone marrow stromal cells, in conjunction with ceramic scaffolds, show great promise for application in human patients, and are already in use in a limited number of clinical trials. In preparing for clinical trials, scale-up current good manufacturing processes (cGMP) must incorporate the use of appropriate assays to ensure that the resulting cell product has maintained its biological activity. Future developments are needed to identify better scaffolds, and better ways to deliver cells with either injectable carriers, or by developing techniques to aide in their escape from the circulation and their incorporation into the pre-existing tissue. Lastly, development of methods that faithfully direct pluripotent stem cell differentiation into populations of osteogenic precursors (and ideally, containing skeletal stem cells) represents a new challenge in the field of bone regeneration, but also offer new opportunities to not only to study the biology of bone formation, but also to develop a robust cell source for bone regeneration.
Insights
Bone regeneration strategies using bone marrow stromal cells and ceramic scaffolds show promise for patients. Future research focuses on improved scaffolds, cell delivery, and pluripotent stem cell differentiation for enhanced bone repair.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Stem Cell Biology
Background:
- Bone marrow stromal cells (BMSCs) combined with ceramic scaffolds are promising for bone regeneration.
- Current clinical trials are limited, necessitating manufacturing process optimization.
- Ensuring biological activity of cell products through validated assays is crucial for clinical translation.
Purpose of the Study:
- To review current advancements in bone regeneration.
- To identify key challenges and future directions in the field.
- To explore the potential of pluripotent stem cells in bone tissue engineering.
Main Methods:
- Review of existing literature on bone regeneration techniques.
- Analysis of current good manufacturing processes (cGMP) for cell-based therapies.
- Discussion of scaffold development and cell delivery systems.
Main Results:
- Bone marrow stromal cells and ceramic scaffolds demonstrate significant potential for bone repair.
- Scale-up of cGMP processes requires robust assays to maintain cell product viability.
- Injectable carriers and enhanced cell circulation/incorporation are areas for development.
Conclusions:
- Further research is needed for improved scaffolds and cell delivery methods.
- Directing pluripotent stem cell differentiation into osteogenic precursors offers a novel cell source.
- Advancements in stem cell technology can enhance the study and treatment of bone defects.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Whole Body Regeneration
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Bone Remodeling

